When injected into a trained muscle group, it can: Stimulate rapid muscle hypertrophy and hyperplasia Support accelerated joint, tendon, and ligament repair Improve nutrient uptake and vascularity in target tissues Complement GH secretagogues like MK-677 (Ibutamoren), CJC-1295, and Ipamorelin Originally developed to help treat muscle wasting and injury-related degeneration , IGF-1 DES has become a valuable off-label peptide in the performance world particularly for: Bodybuilders looking to bring up lagging muscle groups Athletes recovering from injuries Biohackers aiming to enhance connective tissue resilience and regeneration As Philippou et al
Future uses of GLP-1 may also include the treatment of obesity, as well as the adjunctive treatment of type 1 diabetes mellitus in combination with insulin
Clinical trials tracking 68 weeks of semaglutide therapy show average weight loss of 1215% of starting body weight, with some patients exceeding 20% loss at higher doses combined with lifestyle modification
Researchers investigate Tirzepatide to better understand how GIP and GLP-1 signaling pathways interact within complex biological systems
A footnote on whats not a bet the next-generation Indian molecules not Beneath the semaglutide land grab, three Indian companies are quietly building their own proprietary metabolic drugs ones that could end up mattering more than any generic launch
[cited 2023 Nov 17]